Lymphoma & Myeloma

Conference Coverage

Why CLL may go chemo free

NEW YORK – The approach to treating chronic lymphocytic leukemia is evolving, and while chemoimmunotherapy remains a reasonable initial option in...

Conference Coverage

Rethinking testing in multiple myeloma

NEW YORK—As the number of therapeutic options for multiple myeloma (MM) increases, so too does the need to reassess prognostic markers for the...